Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms

Human Pathology

Volumn 27, Issue 2, 1996, Pages 119-124

  Day, John D ^b   Digiuseppe, Joseph A ^b   Yeo, Charles ^b   Lai Goldman, Myla ^b   Anderson, Steven M ^b   Goodman, Steven N ^b   Kern, Scott E ^b   Hruban, Ralph H ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NONE

Author keywords

c erbB 2; HER 2 neu; pancreatic duct hyperplasia; pancreatic neoplasm

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MEMBRANE PROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PANCREATICODUODENECTOMY; PROTO ONCOGENE;

EID: 0030030897     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(96)90364-0     Document Type: Article

References (37)

1. Warshaw AL, Castillo CFD: Pancreatic carcinoma. N Engl J Med 326:455-465, 1992
2. Cubilla AL, Fitzgerald PJ: Morphological lesions associated with human primary invasive nonendocrine pancreas cancer. Cancer Res 36:2690-2698, 1976
3. Kozuka S, Sassa R, Taki T, et al: Relation of pancreatic duct hyperplasia to carcinoma. Cancer 43:1418-1428, 1979
4. Klöppel G, Bommer G, Rückert K, et al: Intraductal prolifertion in the pancreas and its relationship to human and experimental carcinogenesis. Virchows Arch [A] Histology 387:221-233, 1980
5. DiGiuseppe JA, Hruban RH, Offerhaus GJA, et al: Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma. Am J Pathol 144:889-895, 1994
6. Caldas C, Hahn SA, Hruban RH, et al: Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia. Cancer Res 54:3568-3573, 1994
7. Yanagisawa A, Ohtake K, Ohashi K, et al: Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation. Cancer Res 953-956, 1993
8. DiGiuseppe JA, Hruban RH: Pathobiology of cancer of the pancreas. Semin Surg Oncol 11:87-96, 1995
9. Hruban RH, DiGiuseppe JA, Offerhaus GJA: K-ras mutations in pancreatic ductal proliferative lesions: Authors reply. Am J Pathol 145:1547-1550, 1994 (letter)
10. Akiyama T, Sudo C, Ogawa H, et al: The product of human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232:1644-1646, 1986
11. Coussens L, Yang-Feng TL, Yu-Cheng L, et al: Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139, 1985
12. Slamon DJ, Clark GM, Wong SG, et al: Human breast cancer: Correlation of relapse and survival with amplification of the erbB-2/ neu oncogene. Science 235:177-182, 1987
13. Slamon DJ, Godolphin W, Jones LA, et al: Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712, 1989
14. Yonemura Y, Ninomiya I, Yamaguchi A, et al: Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Cancer Res 51:1034-1038, 1991
15. Hall PA, Hughes CM, Staddon SL, et al: The c-erbB-2 protooncogene in human pancreatic cancer. J Pathol 161:195-200, 1990
16. Satoh K, Sasano H, Shimosegawa T, et al: An immunohistochemical study of the c-erbB-2 oncogene product in intraductal mucinhypersecreting neoplasms and in ductal cell carcinoma of the pancreas. Cancer 72:51-56, 1993
17. Williams TM, Weiner DB, Greene MI, et al: Expression of c-erbB-2 in human pancreatic adenocarcinomas. Pathobiology 59:46-52, 1991
18. Yamao K, Nakazawa S, Fujimoto M, et al: A mucous histochemical and immunohistochemical study of precancerous and neoplastic lesions in the human pancreas. Int J Pancreatol 14:37-44, 1993
19. Fendly BM, Winget M, Hudzick RM, et al: Characterization of murine monoclonal antibodies to either epidermal growth factor receptor or Her2/neu gene product. Cancer Res 50:1550-1558, 1990
20. Yeo CJ, Cameron JL, Lillemoe KD, et al: Pancreaticoduode-nectomy for cancer of the head of the pancreas: 201 consecutive patients. Ann Surg 221:721-725, 1995
21. DiGiuseppe JA, Yeo CJ, Hruban RH: Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv Anat Pathol (in press)
22. Lemoine NR, Hall PA: Growth factors and oncogenes in pancreatic cancer. Baillière's Clin Gastroenterol 4:815-832, 1990
23. King CR, Kraus MH: Amplification of a novel v-erbB related gene in human mammary carcinoma. Science 229:974-976, 1985
24. Pierce JH, Arnstcin P, DiMarco E, et al: Oncogcnic potential of erbB-2 in human mammary epithelial cells. Oncogene 6:1189-1194, 1991
25. Schimmelpenning H, Eriksson ET, Falkmer UG, et al: Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma. Virchows Arch A Pathol Anat 420:433-440, 1992
26. Lodato RF, Maguire HC, Greene MI, et al: Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol 3:449-454, 1990
27. DiGiuseppe JA, Hruban RH, Goodman SN, et al: Overexpression of p53 protein in adenocarcinoma of the pancreas. Am J Clin Pathol 101:684-688, 1994
28. Shimizu M, Itoh H, Okumura S: Papillary hyperplasia of the pancreas. HUM PATHOL 20:806-807, 1989
29. Obara T, Saitoh Y, Maguchi H: Multicentric development of pancreatic intraductal carcinoma through atypical papillary hyperplasia. HUM PATHOL 23:82-85, 1992
30. Hruban RH, vanMansfeld ADM, Offerhaus GJA, et al: K-ras oncogene activation in adenocarcinoma of the human pancreas: A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligo-nucleotide hybridization. Am J Pathol 143:545-554, 1993
31. Drebin JA, Link VC, Greene ML: Monoclonal antibodies specific for the neu oncogene product directly mediate anti-tumor effects in vivo. Oncogene 2:387-394, 1988
32. Stancovski I, Hurwitz E, Leitrner D, et al: Mechanistic aspects of the opposing effects of monoclonal antibodies to the criB-2 receptor on tumor growth. Proc Natl Acad Sci U S A 88:8691-8695, 1991
33. Inaji H, Koyama H, Motomura K, et al: erbB-2 protein levels in nipple discharge: Role in diagnosis of early breast cancer. Tumor Biol 14:271-278, 1993
34. McKenzie SJ, Marks PJ, Lam T, et al: Generation and characterization of monoclonal antibodies specific for the human neu oncogene product. Oncogene 4:543-548, 1989
35. Lemoine NR, Hughes SM, Barton CM, et al: The epidermal growth factor receptor in human pancreatic cancer. J Pathol 161:195-200, 1990
36. Kraus MH, Popescu NC, Amsbaugh SC, et al: Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J 6:605-610, 1987
37. Venter DJ, Tuzi NL, Kumar S, et al: Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: Immunohistological assessment correlates with gene amplification. Lancet 2:69-72, 1987